We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to apply for simultaneous review of veterinary medicine submissions to the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the VMD.
How to make sure that your products are properly checked for conformity and your technical documents are managed correctly.
How test manufacturers or distributors can apply for approval of their tests to sell on the UK market.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access partners. The Biosimilar Work Sharing Initiative (BSWSI) builds on this success.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
How to use a patient-reported outcomes and experiences study to evaluate your digital health product.
How to prepare and analyse the data you collected for your evaluation.
How to use focus groups to evaluate your digital health product.
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
This webinar looks at the information an organisation makes available to clients, or potential clients, and how the consumer's expectations can be met.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.
Our Assurance products and guidance has been updated. Related guidance and tools are being refreshed and future revised versions will be published on an iterative basis. To ensure you are using the latest versions, you are advised to regularly access...
Information for manufacturers.
How to ensure the products you make or import comply with the law and are safe for consumers to use.
What you need to know about and do to comply with the law and keep consumers safe.
Documents relating to the independent review led by Paul Morrell OBE and Anneliese Day KC.
Emerging Insights from DFID funded food markets programme in East and Southern Africa.
How the MHRA makes decisions on what is a medicinal product (borderline products).
The process for the simultaneous review of veterinary medicine submissions by Switzerland’s Swissmedic and the UK's Veterinary Medicines Directorate.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).